Javascript must be enabled to continue!
Prophylactic anticonvulsants in patients (pts) with primary brain tumor (PBT): Have we really agreed to a consensus?
View through CrossRef
2060 Background: Routine prophylactic antiepileptic drugs (AED) use to prevent seizures in PBT seizure-naïve pts is not supported by current guidelines. However, the best management of prophylactic AED started in the perioperative setting is still unclear. Additionally, AED can have serious side effects, might have a negative impact on cognition and may present significant drug interactions. Little is known about actual current practice patterns regarding prophylactic AED in PBT. In this report we investigated prophylactic AED use in a tertiary care institution. Methods: We reviewed medical files of 260 consecutive patients, registered in our center between 2008 and 2012, focusing on prophylactic AED use. Collected data included: patient demographics, starting date, AED type, and indication. A descriptive analysis was performed with SPSS IBM version 20.0. Results: Median age was 44.5 years (11 - 83). Most pts had an ECOG PS ≤ 1 (76.4%). Overall, AED were used by 218 pts. Most common agents were: phenytoin (68.8%), carbamazepine (27.1%) and phenobarbital (16.1%). Among 141 seizure-naïve pts, 99 (70.2%) received AED as primary prophylaxis (PP). Only 14 pts (14.1%) had the drug eventually discontinued, in a median time of 5.9 months (1.1 – 76.8m). AED were used as PP in 60% of pts with low-grade gliomas, 73.3% with anaplastic gliomas and 93.9% with glioblastomas. Twenty-seven pts (27.3%) on PP presented seizures, generally associated with tumor progression. For most of them a new anticonvulsant was added for seizure control. Of the 42 seizure-naïve pts who did not receive prophylactic AED, only two presented seizures during or within the first week post-radiotherapy. Conclusions: In our study population, prophylactic AED use in PBT was extremely high (70.2% of seizure-naive pts). Postoperatively, AED were discontinued in a small minority of pts, and even so, only after a prolonged period of time. Very few seizures occurred in pts not receiving prophylactic AED. Our results suggest that practice patterns regarding prophylactic AED in PBT still contradict established guidelines.
American Society of Clinical Oncology (ASCO)
Title: Prophylactic anticonvulsants in patients (pts) with primary brain tumor (PBT): Have we really agreed to a consensus?
Description:
2060 Background: Routine prophylactic antiepileptic drugs (AED) use to prevent seizures in PBT seizure-naïve pts is not supported by current guidelines.
However, the best management of prophylactic AED started in the perioperative setting is still unclear.
Additionally, AED can have serious side effects, might have a negative impact on cognition and may present significant drug interactions.
Little is known about actual current practice patterns regarding prophylactic AED in PBT.
In this report we investigated prophylactic AED use in a tertiary care institution.
Methods: We reviewed medical files of 260 consecutive patients, registered in our center between 2008 and 2012, focusing on prophylactic AED use.
Collected data included: patient demographics, starting date, AED type, and indication.
A descriptive analysis was performed with SPSS IBM version 20.
Results: Median age was 44.
5 years (11 - 83).
Most pts had an ECOG PS ≤ 1 (76.
4%).
Overall, AED were used by 218 pts.
Most common agents were: phenytoin (68.
8%), carbamazepine (27.
1%) and phenobarbital (16.
1%).
Among 141 seizure-naïve pts, 99 (70.
2%) received AED as primary prophylaxis (PP).
Only 14 pts (14.
1%) had the drug eventually discontinued, in a median time of 5.
9 months (1.
1 – 76.
8m).
AED were used as PP in 60% of pts with low-grade gliomas, 73.
3% with anaplastic gliomas and 93.
9% with glioblastomas.
Twenty-seven pts (27.
3%) on PP presented seizures, generally associated with tumor progression.
For most of them a new anticonvulsant was added for seizure control.
Of the 42 seizure-naïve pts who did not receive prophylactic AED, only two presented seizures during or within the first week post-radiotherapy.
Conclusions: In our study population, prophylactic AED use in PBT was extremely high (70.
2% of seizure-naive pts).
Postoperatively, AED were discontinued in a small minority of pts, and even so, only after a prolonged period of time.
Very few seizures occurred in pts not receiving prophylactic AED.
Our results suggest that practice patterns regarding prophylactic AED in PBT still contradict established guidelines.
Related Results
Low-Dose Venetoclax (7 Days) Combined with G-CSF, Fludarabine, High-Dose Cytarabine, and Mitoxantrone (FLAG Mitox-Ven): A Safe and Efficient Regimen, and an Excellent Bridge for Allogeneic Hematopoietic Stem Cell Transplant for Relapse/Refractory Acute My
Low-Dose Venetoclax (7 Days) Combined with G-CSF, Fludarabine, High-Dose Cytarabine, and Mitoxantrone (FLAG Mitox-Ven): A Safe and Efficient Regimen, and an Excellent Bridge for Allogeneic Hematopoietic Stem Cell Transplant for Relapse/Refractory Acute My
Background:
Venetoclax (Ven) combined with FLAG-Ida (G-CSF, Fludarabine, Cytarabine, Idarubicin) represents an effective therapy for relapse/refractory (R/R) acut...
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash
INTRODUCTION
The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Extracorporeal Photopheresis (ECP) As Part of Combined Effective Immunotherapy Treatment of Graft-Versus-Host Disease
Extracorporeal Photopheresis (ECP) As Part of Combined Effective Immunotherapy Treatment of Graft-Versus-Host Disease
Abstract
Abstract 1953
Objective.
Graft-vs-host disease (GVHD) is a serious complication after allogeneic hematop...
Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation
Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation
Abstract
Introduction
Extranodal NK/T-cell lymphoma (ENKTL) is a rare disease; in Western countries it represents less than 1% of all Non-Hodgkin lymp...
Pilot Study with Lenalidomide in Patients with POEMS Syndrome
Pilot Study with Lenalidomide in Patients with POEMS Syndrome
Abstract
Abstract 4612
Introduction:
POEMS syndrome is a rare multisystemic disease. Vascular endothelial growth ...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients
Characteristics and Outcomes of Therapy-Related Acute Myeloid Leukemia: Results of Retrospective Analysis of 116 Adult Patients
Background:Therapy related acute myeloid leukemia (t-AML) is a late complication following cytotoxic therapy for a primary neoplasm or a non-neoplastic disorder as autoimmune disea...
Primary Plasma Cell Leukemia: Results of a Retrospective Italian Multicentric Survey.
Primary Plasma Cell Leukemia: Results of a Retrospective Italian Multicentric Survey.
Abstract
Abstract 2885
Poster Board II-861
Background:
Epidemiological and clinical information on...

